Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Aghokeng, Avelin F ^a,b   Mpoudi Ngole, Eitel ^a   Dimodi, Henriette ^a   Atem Tambe, Arrah ^a   Tongo, Marcel ^a   Butel, Christelle ^b   Delaporte, Eric ^b   Peeters, Martine ^b  

^a Institut de Recherche pour le Developpement Cameroon   (Cameroon)

^b UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ALGORITHM; ARTICLE; CAMEROON; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROLOGY; ANALYTICAL EQUIPMENT; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INSTRUMENTATION; LABORATORY DIAGNOSIS; MASS SCREENING; METHODOLOGY; PREDICTION AND FORECASTING; REPRODUCIBILITY; SERODIAGNOSIS; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AIDS SERODIAGNOSIS; ALGORITHMS; ANTI-RETROVIRAL AGENTS; CAMEROON; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HIV INFECTIONS; HIV-1; HUMANS; MASS SCREENING; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 70450164403     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007702     Document Type: Article

References (25)

1. WHO/UNAIDS (2007) Guidance on provider-initiated HIV testing and counselling in health facilities. Available: http://www.who.int/hiv/pub/ vct/pitc2007/en/index.html. Accessed 2009 May 16.
2. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373: 48-57.
3. Loussert-Ajaka I, Ly TD, Chaix ML, Ingrand D, Saragosti S, et al. (1994) HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 343: 1393-1394.
4. Apetrei C, Loussert-Ajaka I, Descamps D, Damond F, Saragosti S, et al. (1996) Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions. Aids 10: F57-60.
5. Constantine NT, Zink H (2005) HIV testing technologies after two decades of evolution. Indian J Med Res 121: 519-538.
6. Gurtler L, Muhlbacher A, Michl U, Hofmann H, Paggi GG, et al. (1998) Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay. J Virol Methods 75: 27-38.
7. Weber B, Fall EH, Berger A, Doerr HW (1998) Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J Clin Microbiol 36: 2235-2239.
8. Corcoran C, Hardie D (2008) HIV-1 subtype C seronegative AIDS. Clin Infect Dis 46: 322-323.
9. Gautheret-Dejean A, Mesmin-Poho S, Birguel J, Lemee V, Huraux JM, et al. (2008) Unequal detection of HIV type 1 group O infection by simple rapid tests. Clin Infect Dis 46: 1936-1937.
10. Novitsky V, Gaolathe T, Woldegabriel E, Makhema J, Essex M (2007) A seronegative case of HIV-1 subtype C infection in Botswana. Clin Infect Dis 45: e68-71.
11. Aghokeng AF, Ewane L, Awazi B, Nanfack A, Delaporte E, et al. (2004) Evaluation of four simple/rapid assays and two fourth-generation ELISAs for the identification of HIV infection on a serum panel representing the HIV-1 group M genetic diversity in Cameroon. J Acquir Immune Defic Syndr 37: 1632-1640.
12. Mahe C, Kaleebu P, Ojwiya A, Whitworth JA (2002) Human immunodeficiency virus type 1 Western blot: revised diagnostic criteria with fewer indeterminate results for epidemiological studies in Africa. Int J Epidemiol 31: 985-990.
13. Rouet F, Ekouevi DK, Inwoley A, Chaix ML, Burgard M, et al. (2004) Field evaluation of a rapid human immunodeficiency virus (HIV) serial serologic testing algorithm for diagnosis and differentiation of HIV type 1 (HIV-1), HIV-2, and dual HIV-1-HIV-2 infections in West African pregnant women. J Clin Microbiol 42: 4147-4153.
14. Ayouba A, Mauclere P, Martin PM, Cunin P, Mfoupouendoun J, et al. (2001) HIV-1 group O infection in Cameroon, 1986 to 1998. Emerg Infect Dis 7: 466-467.
15. Simon F, Mauclere P, Roques P, Loussert-Ajaka I, Muller-Trutwin MC, et al. (1998) Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 4: 1032-1037.
16. Simon F, Souquiere S, Damond F, Kfutwah A, Makuwa M, et al. (2001) Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses. AIDS Res Hum Retroviruses 17: 937-952.
17. Vergne L, Bourgeois A, Mpoudi-Ngole E, Mougnutou R, Mbuagbaw J, et al. (2003) Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage. Virology 310: 254-266.
18. Fransen K, Zhong P, De Beenhouwer H, Carpels G, Peeters M, et al. (1994) Design and evaluation of new, highly sensitive and specific primers for polymerase chain reaction detection of HIV-1 infected primary lymphocytes. Mol Cell Probes 8: 317-322.
19. Van Heuverswyn F, Li Y, Bailes E, Neel C, Lafay B, et al. (2007) Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon. Virology 368: 155-171.
20. Yang C, Dash BC, Simon F, van der Groen G, Pieniazek D, et al. (2000) Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs. J Infect Dis 181: 1791-1795.
21. UNAIDS (2008) Cameroon-country progress report. Available: http://data.unaids.org/pub/Report/2008/ cameroon_2008_country_progress_report_fr.pdf. Accessed 2009 May 16.
22. WHO/CDC (2001) Guidelines for Appropriate Evaluations of HIV Testing Technologies in Africa. Available: http://www.afro.who.int/aids/ laboratory_services/resources/hiv_test_evaaluation_guidelines.pdf. Accessed 2009 May 16.
23. Urassa W, Nozohoor S, Jaffer S, Karama K, Mhalu F, et al. (2002) Evaluation of an alternative confirmatory strategy for the diagnosis of HIV infection in Dar Es Salaam, Tanzania, based on simple rapid assays. J Virol Methods 100: 115-120.
24. Klarkowski DB, Wazome JM, Lokuge KM, Shanks L, Mills CF, et al. (2009) The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm. PLoS ONE 4: e4351.
25. Mfinanga GS, Mutayoba B, Mbogo G, Kahwa A, Kimaro G, et al. (2007) Quality of HIV laboratory testing in Tanzania: a situation analysis. Tanzan Health Res Bull 9: 44-47.